Massive cancer databank aims to personalize treatment

NCT ID NCT05061342

Recruiting now Knowledge-focused Sponsor: Fengming Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a large databank of blood, imaging, and tissue samples from 5,000 cancer patients. Researchers will track how patients respond to various treatments—including surgery, radiation, and chemotherapy—and look for biomarkers that predict tumor control, side effects, and quality of life. The goal is to better understand which treatments work best for which patients, but this is an observational study, not a test of a new therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this databank could help doctors predict which cancer treatments work best for each patient, improving personalized care.
What could go wrong: This is an observational study, not a treatment trial. It collects data but does not test any new drug or therapy, so it won't directly change patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

UHongKongShenzhen
RECRUITING

Shenzhen, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.